It has been about a month since the last earnings report for Recursion Pharmaceuticals (RXRX). Shares have added about 6.5% in that time frame, outperforming the S&P 500. But investors have to be ...

AI companies are continuing to pour ungodly amounts of money into building out data centers, in an enormous bet that both analysts and tech leaders warn may not pay off for many years to come — if it ...

Alphabet's valuation looks high, but the catalysts suggest shares remain undervalued. Google Cloud's AI-driven backlog signals accelerating multi-year revenue growth for GOOGL. TPUs could evolve into ...

It's been a decade of dominance for growth stocks. Over the past 10 years, the growth ETF has generated a cumulative total return of 389.7%, or an average annual return of 17.2%, as of the end of ...

Massive debt rarely comes from single large purchases. Small, recurring expenses accumulate into serious financial problems without triggering alarm bells. These purchases feel insignificant ...

The Magnificent Seven represent 34.3% of the S&P 500 as of December 2025, up from 12.3% in 2015. From 2015 to 2024, these seven companies achieved a 697.6% return, outperforming the S&P 500. The S&P ...

We’ll explore how Array’s integration of APA’s fixed-tilt and A-frame designs opens new possibilities in difficult terrains and why foundation choice is critical to structural resilience and long-term ...